{
  "denotations": [
    {
      "id": "T1",
      "obj": "Chemical",
      "span": {
        "begin": 69,
        "end": 79
      }
    },
    {
      "id": "T4",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 151,
        "end": 157
      }
    },
    {
      "id": "T5",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 233,
        "end": 239
      }
    },
    {
      "id": "T6",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 295,
        "end": 301
      }
    },
    {
      "id": "T9",
      "obj": "Chemical",
      "span": {
        "begin": 47,
        "end": 49
      }
    },
    {
      "id": "T12",
      "obj": "Chemical",
      "span": {
        "begin": 209,
        "end": 215
      }
    },
    {
      "id": "T13",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 113,
        "end": 119
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "27217047_10",
  "text": "However , in patients who were co-administered AZ , the C0 values of tacrolimus were higher in patients with the CYP3A5 * 3 / * 3 allele than with the CYP3A5 * 1 allele ( P = 0.034 ) , although daily doses of Tac-QD in patients with CYP3A5 * 3 / * 3 were significantly lower than those with the CYP3A5 * 1 allele ( P = 0.041 ) ."
}
